Drug therapy for children in China.
The population of China is huge and includes 400 million children. For China, as for other countries in the world, there remain a number of questions from the past about drug therapy for children, such as unlicensed and off-label drug usage. Recently, China has updated Good Clinical Practice (GCP) guidelines, including those for pediatric drug clinical trials. Pediatric pharmacology research units need to be set up throughout the country. To provide better medicines to children in China is an enormous undertaking.